198 related articles for article (PubMed ID: 26754854)
1. Molecular characterization of hepatitis C virus core region in moroccan intravenous drug users.
Trimbitas RD; Fayssel N; Serghini FZ; Wakrim L; Khyatti M; Essalhi M; Bellefquih AM; Benani A
J Med Virol; 2016 Aug; 88(8):1376-83. PubMed ID: 26754854
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus genotype 1: how genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy.
Alhamlan FS; Al-Ahdal MN; Khalaf NZ; Abdo AA; Sanai FM; Al-Ashgar HI; Elhefnawi M; Zaid A; Al-Qahtani AA
J Med Virol; 2014 Feb; 86(2):224-34. PubMed ID: 24166351
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the STAT1‑interacting domain of the hepatitis C virus core protein modulate the response to antiviral therapy.
Anjum S; Afzal MS; Ahmad T; Aslam B; Waheed Y; Shafi T; Qadri I
Mol Med Rep; 2013 Aug; 8(2):487-92. PubMed ID: 23799612
[TBL] [Abstract][Full Text] [Related]
4. The "hidden" epidemic: a snapshot of Moroccan intravenous drug users.
Trimbitas RD; Serghini FZ; Lazaar F; Baha W; Foullous A; Essalhi M; El Malki A; Meziane Bellefquih A; Bennani A
Virol J; 2014 Mar; 11():43. PubMed ID: 24602336
[TBL] [Abstract][Full Text] [Related]
5. Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South Africa.
Prabdial-Sing N; Blackard JT; Puren AJ; Mahomed A; Abuelhassan W; Mahlangu J; Vermeulen M; Bowyer SM
Antiviral Res; 2016 Mar; 127():90-8. PubMed ID: 26704023
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of hepatitis C virus for determination of subtypes and detection of resistance mutations to protease inhibitors in a group of intravenous drug users co-infected with HIV.
Silva T; Cortes Martins H; Coutinho R; Leitão E; Silva R; Pádua E
J Med Virol; 2015 Sep; 87(9):1549-57. PubMed ID: 25940586
[TBL] [Abstract][Full Text] [Related]
7. Influence of amino acid variations in the NS3, NS4A and NS4B of HCV genotypes 1a, 1b, 3a, 3b and 6f on the response to pegylated interferon and ribavirin combination therapy.
Chusri P; Kumthip K; Pantip C; Thongsawat S; O'Brien A; Maneekarn N
Virus Res; 2015 Jan; 196():37-43. PubMed ID: 25445343
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
[TBL] [Abstract][Full Text] [Related]
9. HCV dispersal patterns among intravenous drug users (IDUs) in Athens metropolitan area.
Papachristou E; Tsagkovits A; Zavitsanou A; Hatzakis A; Paraskevis D
Infect Genet Evol; 2016 Nov; 45():415-419. PubMed ID: 27721034
[TBL] [Abstract][Full Text] [Related]
10. Recombination in hepatitis C virus is not uncommon among people who inject drugs in Kolkata, India.
Gupta D; Saha K; Biswas A; Firdaus R; Ghosh M; Sadhukhan PC
Infect Genet Evol; 2017 Mar; 48():156-163. PubMed ID: 27923769
[TBL] [Abstract][Full Text] [Related]
11. Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.
Aitken CK; Tracy SL; Revill P; Bharadwaj M; Bowden DS; Winter RJ; Hellard ME
J Clin Virol; 2008 Apr; 41(4):293-6. PubMed ID: 18242125
[TBL] [Abstract][Full Text] [Related]
12. [Evolutionary characteristics and positive selection site of hepatitis C virus isolated in intravenous drug users in Pudong new district, Shanghai].
Wang Y; Wu HY; Zhao XC; Zhu WP; Wan Q; Lu YH; Jiang QW
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Mar; 38(3):378-383. PubMed ID: 28329944
[No Abstract] [Full Text] [Related]
13. Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin.
Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
J Med Virol; 2010 Apr; 82(4):575-82. PubMed ID: 20166188
[TBL] [Abstract][Full Text] [Related]
14. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam.
Tanimoto T; Nguyen HC; Ishizaki A; Chung PT; Hoang TT; Nguyen VT; Kageyama S; Oka S; Pham VT; Ichimura H
J Med Virol; 2010 Aug; 82(8):1355-63. PubMed ID: 20572071
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
[TBL] [Abstract][Full Text] [Related]
16. [Distribution of Hepatitis C Virus (HCV) Genotypes Among Intravenous Drug and Non-Drug User Patients].
Erman Daloğlu A; Parkan ÖM; Erdoğan A; Peker BO; Can Sarınoğlu R; Sağlık İ; İnan D; Kuloğlu MM; Mutlu D; Öngüt G; Çolak D
Mikrobiyol Bul; 2021 Jan; 55(1):30-40. PubMed ID: 33590979
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus molecular epidemiology in Uzbekistan.
Kurbanov F; Tanaka Y; Sugauchi F; Kato H; Ruzibakiev R; Zalyalieva M; Yunusova Z; Mizokami M
J Med Virol; 2003 Mar; 69(3):367-75. PubMed ID: 12526047
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment.
Bolcic F; Sede M; Moretti F; Westergaard G; Vazquez M; Laufer N; Quarleri J
Arch Virol; 2012 Apr; 157(4):703-11. PubMed ID: 22270759
[TBL] [Abstract][Full Text] [Related]
19. A nucleotide sequence variation detection system for the core region of hepatitis C virus-1b.
Okamoto K; Akuta N; Kumada H; Kobayashi M; Matsuo Y; Tazawa H
J Virol Methods; 2007 Apr; 141(1):1-6. PubMed ID: 17184852
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates.
Jaspe RC; Sulbarán YF; Sulbarán MZ; Loureiro CL; Rangel HR; Pujol FH
Virol J; 2012 Sep; 9():214. PubMed ID: 22995142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
